Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: michael_f_murphy who wrote (1179)	5/6/2002 8:59:34 PM
From: scaram(o)uche	Respond to of 2243

Close enough, but you obviously made a $0.75 error somewhere. ;-)

To: michael_f_murphy who wrote (1179)	5/6/2002 9:01:32 PM
From: scaram(o)uche	Respond to of 2243

HCV program supposedly has depth and breadth. Add $0.75.

To: michael_f_murphy who wrote (1179)	5/6/2002 9:10:55 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2243

>> I swag the debt drag at -$60M present value << What if the debt could be used to support the growth of an approved product, say by a KOSP or a SCIO? In a stock for stock transaction, I believe that the debt can't be called? What would VPHM be worth to someone who wanted to grow a business and add to pipe? 180M? You can consider this one "too silly to address" if you like, and shine me on. Thanks, very much, for your analysis. Cheers! Rick